Akoya Biosciences (AKYA)
(Delayed Data from NSDQ)
$3.20 USD
+0.07 (2.24%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $3.19 -0.01 (-0.31%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$3.20 USD
+0.07 (2.24%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $3.19 -0.01 (-0.31%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth D Momentum C VGM
Zacks News
Emergent Biosolutions (EBS) Q1 Earnings Lag Estimates
by Zacks Equity Research
Emergent Biosolutions (EBS) delivered earnings and revenue surprises of -25% and 3.86%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for April 11th
by Zacks Equity Research
DDD, ADAP, and AKYA have been added to the Zacks Rank #5 (Strong Sell) List on April 11, 2022.
New Strong Sell Stocks for April 1st
by Zacks Equity Research
AKYA, AMPE, and BITF have been added to the Zacks Rank #5 (Strong Sell) List on April 1, 2022.
New Strong Sell Stocks for March 17th
by Zacks Equity Research
DDD, ADAP, and AKYA have been added to the Zacks Rank #5 (Strong Sell) List on March 17, 2022.
Can Earthstone (ESTE) Q4 Earnings Maintain Positive Surprise?
by Zacks Equity Research
While higher prices and production are likely to have boosted Earthstone Energy's (ESTE) profit levels in the fourth quarter, escalation in costs might have played spoilsport.
Canadian Natural (CNQ) to Report Q4 Results: What Awaits?
by Zacks Equity Research
While higher prices are likely to have boosted Canadian Natural Resources' (CNQ) profit levels in the fourth quarter, escalation in costs might have played spoilsport.
Is a Surprise Coming for Akoya Biosciences (AKYA) This Earnings Season?
by Zacks Equity Research
Akoya Biosciences (AKYA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.